GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Abbott India ABBOTINDIA.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

26,680.00

+1.27%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Abbott India — daily BSE:ABBOTINDIA End of day BSE listing — our prices are the NSE line

Why two exchanges. Abbott India trades on both NSE and BSE. TradingView's free charts don't carry NSE, so the chart shows the BSE listing. The ticker and close we quote are the NSE line.

Market value
₹566.93bn
Last close × shares
Volume
10.1k
Shares, 9 Nov 2026
Price to earnings
36.7
Dividend yield
2.45%

About Abbott India

Its shares trade on NSE under the ticker ABBOTINDIA.NS. It has been listed since 3 November 1994. In the fiscal year to 31 March 2026, it reported revenue of ₹69.29bn and net income of ₹15.52bn. At that date it held total assets of ₹65.02bn and shareholders' equity of ₹47.74bn.

Abbott India Ltd. engages in the development, manufacture, and sale of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra. The firm has a portfolio of offerings in diagnostics, medical devices, nutrition products and branded generic medicines. The company provides products and solutions across various therapeutic areas, such as women's health, gastroenterology, central nervous system, metabolics, multi-specialty, vaccines and consumer health, among others. Its products include Colospa (irritable bowel disease), Ganaton (gastrointestinal motility), Librax (irritable bowel disease), Zolfresh (insomnia), Thyronorm (hypothyroidism), Duphaston (miscarriage and IVF), Duphalac (constipation), Digene (antacid), Prothiaden (pain and depression), Influvac (prevention of influenza), Creon (pancreatic insufficiency), Cremalax (constipation), Pankreoflat (indigestion) and Duvadilan (preterm labor), among others. The company offers various products under brands, such as Similac, PediaSure, Pedialyte, EleCare, Ensure and Glucerna, among others.

Figures and description from our data supplier, not checked against the company's own report.

More about Abbott India →

Latest on Abbott India

Our reporting

We have not reported on Abbott India yet.

Next results

5 Nov 2026

Due on 5 Nov 2026. Analysts expect earnings of 212.40 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Abbott India's ticker?

Abbott India trades as ABBOTINDIA.NS on NSE, under ISIN INE358A01014.

What was Abbott India's last closing price?

26,680.00 on 9 Nov 2026. The figure is in INR and is never converted.

When does Abbott India next report results?

Results are expected on 5 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.